Xenon Pharmaceuticals Inc.

Nuveen, LLC XENE
Report date
6/30/2026
Quarter
2026 Q2
Filed
8/11/2026
Shares
993,126
Value ($000)
59,945
Weight
0.0%
2025 Q2 - 2026 Q2 (5 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).